| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 05/14/2009 | US20090124673 Method for treating diabetic nephropathy |
| 05/14/2009 | US20090124671 Trpv1 antagonists |
| 05/14/2009 | US20090124667 Novel Dual-Use Peptidase Inhibitors as Prodrugs for a Therapy of Inflammatory and Other Diseases |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/13/2009 | EP2057135A1 Insecticidal n-substituted (2- sudstituted-1,3-thiazol) alkyl sulfoximines |
| 05/13/2009 | EP2057121A2 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | EP2056830A1 Compositions useful especially for treatment or prevention of metabolic syndrome |
| 05/13/2009 | EP1549624B1 Inhibitors of fatty acid amide hydrolase |
| 05/13/2009 | CN101429173A Process for producing pramipexole midbody 2,6-diamino-4,5,6,7-tetrahydrochysene-benzothiazole |
| 05/13/2009 | CN101429164A Levorotation benzhydryl piperazidine derivant and preparing method thereof |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531563 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr) |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | US7531067 Process for purification of 2-chloro-5-chloromethyl-1,3-thiazole |
| 05/12/2009 | CA2199490C Dye couple for spectrophotometric determination of analytes |
| 05/12/2009 | CA2192744C Stable coupling dye for photometric determination of analytes |
| 05/07/2009 | WO2009058997A2 Non-invasive isolation of fetal nucleic acid |
| 05/07/2009 | WO2009057668A1 Amide compound and plant disease control using the same |
| 05/07/2009 | WO2009056811A2 Tetrahydrobenzothiazole derivatives with dopamine receptor activity |
| 05/07/2009 | WO2009056805A1 Medicaments |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009055917A1 Inhibitors of histone deacetylase |
| 05/07/2009 | WO2009036341A3 Compositions and methods relating to hiv protease inhibition |
| 05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
| 05/07/2009 | US20090118516 Process for preparing ligands of ppardelta and the intermediate compounds for preparing the same |
| 05/07/2009 | US20090118510 Dark coloured azo dyes |
| 05/07/2009 | US20090118501 enzyme inhibitor for treating diabetes; 1-(4-Methyl-cyclohexyl)-3-(5-methyl-thiazol-2-yl)-1-(4-oxo-cyclohexyl)-urea |
| 05/07/2009 | US20090118323 Antitumor benzoylsulfonamides |
| 05/07/2009 | US20090118291 Histone deacetylase inhibitors |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | CA2703718A1 Inhibitors of histone deacetylase |
| 05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/06/2009 | EP2055302A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/06/2009 | EP2054397A1 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 05/06/2009 | EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/06/2009 | EP1783120B1 Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | CN101423503A 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-carbomethoxyl cyclopropane)-1,3-benzopyrene and synthetic method thereof |
| 05/06/2009 | CN101423502A 1-heterocycle-5-phenyl-2amylene-1-ones compounds as well as preparation method and application thereof |
| 05/06/2009 | CN101423501A Heterocycle-containing 5-phenyl-2,4-pentadienyl-1-ones compounds as well as preparation method and application thereof |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100484927C 2-difluorophenoxymethylbenzimidazole and synthesis method thereof |
| 05/06/2009 | CN100484524C Thiazolidine carboxamide derivatives as modulators of the prostaglandin receptor |
| 05/05/2009 | US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | US7528133 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 04/30/2009 | WO2009055514A2 Fungicidal compounds and mixtures |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2009054468A1 Azolecarboxamide compound or salt thereof |
| 04/30/2009 | WO2009054390A1 Thiazolidinedione compound |
| 04/30/2009 | WO2009053628A2 Novel compounds, preparation and uses thereof |
| 04/30/2009 | WO2009053449A1 Thiazoles which potentiate ampa receptor and medicinal uses thereof |
| 04/30/2009 | WO2009027077A8 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 04/30/2009 | US20090111855 SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-alpha MODULATORS |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | US20090111794 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 04/30/2009 | US20090111151 Production of Polyketides |
| 04/30/2009 | US20090108733 Precursors of Organometallic Compounds for Electroluminescent Materials |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | CA2703106A1 Azolecarboxamide derivatives as trka inhibitors |
| 04/30/2009 | CA2700915A1 Cyclohexeneamide derivatives and their use as trpv1 antagonist |
| 04/29/2009 | EP2051985A2 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof |
| 04/29/2009 | EP2051971A1 Process for the preparation of pramipexole base and/or its salts |
| 04/29/2009 | EP2051970A1 Substituted azolin-2-yl-amino compounds |
| 04/29/2009 | EP2051964A2 Fatty acid amide hydrolase inhibitors |
| 04/29/2009 | EP1828154B1 Phenyl-piperazin methanone derivatives |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421265A Thiazole compounds as protein kinase b (pkb) inhibitors |
| 04/29/2009 | CN101421255A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 04/29/2009 | CN101421230A Novel phenyl-propargylether derivatives |
| 04/29/2009 | CN101417985A Method for synthesizing 2-amino thizaoline |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482651C Diaminothiazoles |
| 04/29/2009 | CN100482650C Process of synthesizing 4-methyl-5-formyl thiazole |
| 04/29/2009 | CN100482649C Organic compounds |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524878 Phenyl substituted carboxylic acids |
| 04/28/2009 | US7524876 Luciferin derivatives |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524871 Thrombin inhibitors |
| 04/28/2009 | US7524842 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009051718A2 Calcium receptor modulating agents |
| 04/23/2009 | WO2009051223A1 Pharmaceutical composition for treatment of cataract |
| 04/23/2009 | WO2009017822A3 Pi3 kinase modulators and methods of use |
| 04/23/2009 | WO2009012958A3 Tubulysin d analogues |
| 04/23/2009 | WO2006066109A3 Hydroxysteroid dehydrogenase inhibitors |